See it in Search
This page is a preview of the following resource. Continue onto eagle-i search using the button on the right to see the full record.
Nurse-delivered WRITE Symptoms© vs. self-directed WRITE Symptoms© vs. care as usual for optimal symptom management for women with recurrent ovarian, fallopian tube, or primary peritoneal cancer
eagle-i ID
http://hawaii.eagle-i.net/i/00000130-de1b-4af7-9953-50a980000000
Resource Type
Properties
-
-
ClinicalTrials.gov url
-
http://www.clinicaltrials.gov/ct2/show/NCT00958698
-
-
Intervention
-
Written Representational Intervention To Ease (WRITE) symptom management program
-
-
Intervention
-
Assessment of therapy complications
-
-
Intervention
-
Management of therapy complications
-
-
Intervention
-
Psychosocial assessment and care
-
-
Intervention
-
Quality-of-life assessment
-
-
Intervention
-
Educational intervention
-
-
Intervention
-
Internet-based intervention
-
-
Intervention
-
Questionnaire administration
-
-
Intervention
-
Communication intervention
-
-
Additional Topic(s)
-
Psychosocial Effects of Cancer and Its Treatment
-
-
Additional Topic(s)
-
Symptom management
-
-
Resource Description
-
"This randomized clinical trial is studying two different symptom management programs to see how well they work compared with usual care in patients with recurrent or persistent ovarian cancer, fallopian tube cancer, or primary peritoneal cancer."
-
-
Additional Name
-
Symptom Management in Patients With Recurrent or Persistent Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
-
-
Contact
-
Berenberg, Jeffrey
-
-
PI
-
Wilkinson, Robert, M.D.
-
-
Topic
-
peritoneal carcinoma
-
-
Topic
-
fallopian tube cancer
-
-
Topic
-
ovarian cancer
-
-
Study Population
-
Females 18 years and older Diagnosis of ovarian, fallopian tube, or primary peritoneal cancer that has recurred or persisted following primary therapy, and meeting other symptom-related criteria
-
-
Funded by
-
Gynecologic Oncology Group
-
-
Performed by
-
Clinical Protocol & Data Management Shared Resource
